Increased demand for colonoscopies has prompted healthcare leaders to hone preventive screening, service delivery and innovation strategies in recent years.1
Uncategorized
Boston-based Dana-Farber Cancer Institute will lead 12 other health systems and academic institutions across the U.S. in a new cancer consortium aimed at addressing health equity and survival rates among pediatric populations.
Rockledge, Fla.-based Health First will transfer ownership of its Health First Cancer Institute building to Titusville, Fla.-based Parrish Healthcare as part of the health systems' collaboration.
Leaders from two top-five cancer centers, as ranked by U.S. News & World Report, shared with Becker's the changes they want to see in cancer care.
Hospitals with higher guideline-directed medical therapy scores showed lower rates of mortality, rehospitalization and costs in heart failure patients, according to a Sept. 25 study released by JAMA Cardiology.
Houston-based University of Texas MD Anderson Cancer Center is publishing an open-access, peer-reviewed academic journal. Advances in Cancer Education & Quality Improvement will share research and insights with the aim of improving cancer care and patient outcomes.
Research and consulting firms KS&R and EMI have published a survey of 429 board-certified, practicing cardiologists, highlighting the challenges cardiologists said they are facing with patient care.
Chicago-based Northwestern Medicine has named Hidayatullah Munshi, MD, chief of the hematology and oncology division in the Department of Medicine at the Feinberg School of Medicine.
Orlando-based University of Central Florida College of Medicine and Davie-based HCA Florida Healthcare have launched a cardiovascular disease fellowship, marking the 40th program to be offered through the partnership's Graduate Medical Education Consortium.
Surgeons at Chicago-based Northwestern Medicine have performed a double-lung transplant for a patient with stage 4 colorectal cancer through its double-lung replacement and multidisciplinary care program, a first-of-its-kind initiative reserved for patients whose cancers do not respond to standard treatments.